深圳市市场监管局谱写监管领域综合改革创新示范新篇章

Group 1 - Shenzhen has launched the first national data intellectual property registration service platform and issued the first AI digital human data intellectual property certificates [1][9] - The market supervision bureau has established a mechanism for cultivating innovative products and has been approved for the first AI medical device for cell morphology analysis [1][3] - Shenzhen's market supervision system has implemented five comprehensive reform pilot tasks and has promoted 11 specific reform initiatives nationwide [2][11] Group 2 - The establishment of the first data intellectual property service trust in Shenzhen aims to activate the value of intellectual property and data assets through financial innovation [2][9] - Shenzhen has created a five-in-one overseas intellectual property protection system, providing one-on-one guidance to 2,320 enterprises and recovering over $16 billion in market losses [3][7] - The city has also established a "Hong Kong-Macao drug and device通" real-world research platform, with 75 urgently needed drug and device types approved for implementation [3][6] Group 3 - Shenzhen's market supervision bureau has organized a city-wide roadshow for key innovative medical device projects, with 27 projects participating [4][5] - The bureau has achieved significant results in the approval process for AI medical devices, including the approval of the first AI medical device for cell morphology analysis [5][6] - The city has built a WHO-PQ certified laboratory and established a precise service mechanism for drug supervision and inspection, enhancing its capabilities [6][7] Group 4 - Shenzhen has made significant advancements in the inspection level of biological products, with over 20 new qualifications for cell and gene therapy products [7][8] - The city has optimized the clinical trial mechanism, reducing the average time from project initiation to launch to just 73.27 days [8][11] - The establishment of the first national data intellectual property registration service platform has resulted in the issuance of 1,725 certificates and facilitated 106 million yuan in financing [9][10] Group 5 - The AI medical device industry in Shenzhen is rapidly developing, with over 20% of national AI medical enterprises located in the city [12] - Shenzhen is expected to continue generating replicable and promotable innovative experiences, contributing to high-quality urban development and modernizing market supervision [12][11] - The city has established a collaborative mechanism with Hong Kong's health authorities to explore cross-border data recognition and regulatory cooperation [11][12]